Cancer Pharmacogenetics: The Move from Pharmacokinetics to Pharmacodynamics

E-ISSN： 1875-6204|4|1|39-46

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.4, Iss.1, 2006-03, pp. : 39-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics

By Hasovits Csilla Clarke Stephen

Clinical Pharmacokinetics, Vol. 51, Iss. 4, 2012-04 ,pp. : 203-224

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs

By Sakaeda Toshiyuki Nakamura Tsutomu Okumura Katsuhiko

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 397-410

Future Medicine

Access to resources Recommend Favorite

Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics

By Sehrt Daniel Meineke Ingolf Tzvetkov Mladen Güültepe Senol Brockmööller Jüürgen

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 783-795

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics: focus on pharmacodynamics

By Klaus L. Elizabeth F. Mark C. Ian H.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 74-82

Adis International

Access to resources Recommend Favorite

A review of membrane sampling from biological tissues with applications in pharmacokinetics, metabolism and pharmacodynamics

By Garrison K.E. Pasas S.A. Cooper J.D. Davies M.I.

European Journal of Pharmaceutical Sciences, Vol. 17, Iss. 1, 2002-10 ,pp. : 1-12

Elsevier

Access to resources Recommend Favorite